ARTIFICIAL INTELLIGENCE IS REVOLUTIONIZING PATHOLOGY
Advanced pathology for preclinical research, clinical trials, and decision support
Advancing Research, Improving Patient Outcomes
Take advantage of our high quality histopathology research services to generate quantitative pathology end points.
Access the the most advanced AI-powered digital assay pathology platform in the cloud.
Clinical Decision Support
Incorporate AI-powered pathology decision support tools to improve patient outcomes.
Pathology Powered By
High quality immunohistochemistry (IHC) combined with whole slide imaging and cell-by-cell quantification to advance your research.
Access the most advanced quantitative NASH and fibrosis data from your human or rodent liver samples.
Data powered pathology for advanced research & better patient care
Latest research, in the news, or at events.
Reveal Biosciences Creates A New Artificial Intelligence Approach to Spatial Genomics in Partnership with QuantumCyte
The partnership paves way for the integration of AI-driven spatial genomics with a unique cloud-based platform (SAN DIEGO, Jan. 19, 2021) — Reveal Biosciences, Inc., a leader in AI
Reveal Biosciences’ AI-powered imageDx™ platform expedites pathology review of over 3,500 slides for COVID study
The universal demand to bring a COVID vaccine to market has expedited timelines in both preclinical and clinical research. While vaccine development efforts have been accelerated, traditional pathology evaluation
imageDx™ platform creates a new generation of Pathology Intelligence™ (SAN DIEGO, CA. Jan. 12, 2021) — Reveal Biosciences, Inc., an established AI data provider, has developed a powerful and